GERM
ETFMG Treatments, Testing and Advancements ETF
Set alert
- Open
- 19.28
- Prev close
- 19.16
- Mkt cap
- 9.59M
- Vol
- 4.83K
- Avg vol
- 1.20K
- EPS
- 2.57
- P/E
- 7.45
- Div yield
- 0.00%
More statistics
- Low
- 19.16
- High
- 19.28
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 18.93
- 200-d avg
- 18.53
News
-
2 years ago benzinga.com
Mpox Variant Sparks Global Concern As Europe, China Ramp Up Screening
Increased screening for deadly new version of mpox is seen in Europe and China. More imported cases are expected. New vaccines are being developed.
-
2 years ago benzinga.com
FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch
The FDA may approve updated COVID-19 vaccines this week to combat recent strains as the country endures a significant summer outbreak.
2 years ago globenewswire.com
Amplify ETFs to Liquidate Three ETFs
CHICAGO, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Amplify ETFs, a leading provider of exchange traded funds, today announced the scheduled liquidation of three ETFs (the “Funds”). The Funds scheduled for…
2 years ago etftrends.com
Finding Opportunity in Unloved Healthcare ETFs
Sometimes it feels like it's Nvidia's world and we all just live in it. Why bother with anything else?
3 years ago etftrends.com
Amplify's Christian Magoon on Purchase of ETFMG's ETFs
In June, the ETF industry learned that issuer ETF Managers Group would be selling its funds to Amplify ETFs. The transaction, once completed, will bring Amplify's total AUM to $8 billion invested…
3 years ago etftrends.com
This Week in ETFs: A Summer Slowdown
The week ending Friday, July 21, has been busy for the ETF industry, though launches were muted. A total of seven funds rolled out, which suggests the market could be entering some kind of summer…
3 years ago zacks.com
Biotech ETFs in Focus on Covid Vaccines' Fall Rollout
The FDA advised to Pfizer, Moderna and Novavax to manufacture single-strain jabs targeting the omicron subvariant XBB.1.5 should prove to be a victory for some biotech ETFs.
3 years ago seekingalpha.com
Can Health Care Stocks Outperform Again In 2023?
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
4 years ago zacks.com
Here's Why COVID-Themed ETFs May Come Back Under the Radar
COVID-themed stocks and ETFs were winners in 2020 and some parts of 2021 due to a spike in global coronavirus cases. We may see the same trend again as new COVID variants are 'pretty troublesome.
4 years ago etftrends.com
Biotech ETFs Slip After Novavax Cuts 2022 Guidance
Biotechnology sector-related exchange traded funds retreated with Novavax Inc. (NasdaqGS: NVAX), plunging after the vaccine developer cut its 2022 revenue guidance in half. On Tuesday, the iShares…
4 years ago etftrends.com
Moderna Q2 Earnings, Buyback Plans Lift Biotech ETFs
Moderna Inc (NasdaqGS: MRNA) shares surged Wednesday, lifting biotechnology sector-related exchange traded funds, after the pharmaceutical company revealed better-than-expected profit and revenue in…
4 years ago zacks.com
Pharma & Biotech ETFs at One-Month High: Here's Why
Pharma and biotech ETFs are in great shape and are trading at a one-month high level.
4 years ago etf.com
Vir Jumps 20% On S&P SmallCap 600 News
Currently, 66 ETFs are affected, but it will be added to even more funds soon.
4 years ago etf.com
China ETFs Drop On Audit Enforcement
The first tranche of Chinese ADRs affected by a 2020 law has been released.
4 years ago zacks.com
Biotech ETFs That Outperformed Last Week
Biotech ETFs was the biggest gainer last week.
4 years ago zacks.com
Healthcare Emerges as Best Sector of Last Week: 5 Top ETFs
Wall Street was downbeat last week with all indexes in the red. Still, Healthcare sector emerged as a key winner last week.
4 years ago zacks.com
5 Best Sector ETFs of November
Though the broad markets ended the month in red, a few sector ETFs performed remarkably well.
4 years ago zacks.com
Bet On COVID-Themed ETFs as New Cases Rise Globally
The remainder of 2021 is expected to continue reeling under the spurt in coronavirus cases. Thus, a COVID-themed ETF could be a wise choice.
5 years ago seekingalpha.com
GERM ETF: A New Player In The Infectious Disease Segment
ETF Managers Trust - ETFMG Treatments Testing and Advancements ETF is a biotech focused ETF invested in treatments and therapies firms.
5 years ago zacks.com
7 Best ETFs of the First Nine Months of 2021
We highlight seven ETFs from different segments that have outperformed and gained more than 40% in the first nine months of 2021.
5 years ago zacks.com
Play COVID-Themed ETFs as US Labor Day Sees Rise in New Cases
The remainder of 2021 is expected to continue reeling under the spurt in coronavirus cases. Thus, a COVID-themed ETF could be a wise choice.
5 years ago zacks.com
Healthcare ETFs to Gain on $65-Billion Pandemic Protection Plan
The Biden administration recently offered a $65 billion plan that U.S. officials say is aimed at combating the biological threats after the COVID-19 pandemic goes away.